SARS-CoV-2 Seropositivity and Seroconversion in Patients Undergoing Active Cancer-Directed Therapy is a research paper published in JCO Oncology Practice (2021). On theSindex it has a DataRank of 0.373. It has been cited 3 times, with 3 citing works in its 1-hop citation network.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.208
From this paper's citation signal
Citation Network Contribution
0.165
From 2 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 3 citers.
NCI NIH HHS
Grant: K08 CA215312
NCATS NIH HHS
Grant: UL1 TR001878
NCI NIH HHS
Grant: P30 CA016520
NCATS NIH HHS
Grant: TL1 TR001880
National Institutes of Health
Grant: 3UL1TR001878-06S1
Institutional Clinical and Translational Science Award
National Institutes of Health
Grant: 2P30CA016520-35
Abramson Cancer Center Support Grant
Fundação para a Ciência e a Tecnologia, I.P.
Grant: PTDC/CCI-INF/6762/2020
MS3: New foundations for micro-services and serverless systems
FWCI
0.16
Citation Percentile
0.5%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals